MARKET

IART

IART

Integra Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

68.70
-0.56
-0.81%
Opening 12:26 03/03 EST
OPEN
68.85
PREV CLOSE
69.26
HIGH
70.17
LOW
68.19
VOLUME
41.42K
TURNOVER
--
52 WEEK HIGH
71.34
52 WEEK LOW
34.21
MARKET CAP
5.80B
P/E (TTM)
43.62
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Insider Selling at Integra LifeSciences Holdings (IART) Continues with Significant Sale
MT Newswires · 1d ago
Significant Insider Selling in Shares of Integra LifeSciences Holdings (IART) Continues
MT Newswires · 3d ago
Shares of IART Up 43.3% Since Uptrend Call on Shares
Feb 26, 2021 (SmarTrend(R) Spotlight via COMTEX) -- SmarTrend identified an Uptrend for Integra Lifescie (NASDAQ:IART) on November 5th, 2020 at $48.10. In...
marketwatch.com · 4d ago
Integra LifeSciences Holdings Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Integra LifeSciences Holdings Corporation ( NASDAQ:IART ) came out with its annual results last week, and we wanted to...
Simply Wall St. · 5d ago
Integra (IART) Arms Grow Sequentially Despite Supply Issues
Zacks.com · 02/24 12:51
10-K: INTEGRA LIFESCIENCES HOLDINGS CORP
(EDGAR Online via COMTEX) -- ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The following discussion and...
Edgar Online - (EDG = 10Q, 10K) · 02/23 22:25
Integra (IART) Q4 Earnings Top Estimates, Revenues Fall Y/Y
Zacks.com · 02/19 23:33
DJ Integra LifeSciences Is Maintained at Outperform by Credit Suisse
Dow Jones · 02/19 14:17
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IART. Analyze the recent business situations of Integra Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IART stock price target is 70.33 with a high estimate of 80.00 and a low estimate of 50.00.
EPS
Institutional Holdings
Institutions: 430
Institutional Holdings: 77.96M
% Owned: 92.40%
Shares Outstanding: 84.37M
TypeInstitutionsShares
Increased
81
4.62M
New
43
-480.55K
Decreased
93
2.83M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.72%
Healthcare Equipment & Supplies
-1.81%
Key Executives
Chairman/Independent Director
Stuart Essig
Chief Executive Officer/President/Director
Peter Arduini
Chief Financial Officer/Executive Vice President
Carrie Anderson
Chief Operating Officer/Executive Vice President
Glenn Coleman
Chief Human Resource Officer/Executive Vice President
Lisa Evoli
Executive Vice President/Secretary
Eric Schwartz
Executive Vice President
Robert Davis
Executive Vice President
Michael McBreen
Senior Vice President/Chief Accounting Officer
Jeffrey Mosebrook
Lead Director/Independent Director
Barbara Hill
Independent Director
Rhonda Ballintyn
Independent Director
Keith Bradley
Independent Director
Donald Morel
Independent Director
Raymond Murphy
Independent Director
Christian Schade
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About IART
Integra LifeSciences Holdings Corporation provides regenerative technologies and neurosurgical solutions. The Company offers a portfolio of brands including AmnioExcel, Bactiseal, Certas, Codman, CUSA, DuraGen, DuraSeal, ICP Express, Integra, MediHoney, MicroFrance, PriMatrix, SurgiMend, TCC-EZ, and VersaTru. The Company offers solutions in orthopedics, neurosurgery, and reconstructive and general surgery. The Company operates through two segments: Codman Specialty Surgical segment, and Orthopedics and Tissue Technologies segment. The Codman Specialty Surgical segment includes the Neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care. The Orthopedics and Tissue Technologies segment includes such offerings as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair products.

Webull offers kinds of Integra Lifesciences Holdings Corp stock information, including NASDAQ:IART real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IART stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IART stock methods without spending real money on the virtual paper trading platform.